Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly

被引:10
|
作者
Fukuoka, Hidenori [1 ]
Takahashi, Yutaka [1 ]
Iida, Keiji [1 ]
Kudo, Takumi [1 ]
Nishizawa, Hitoshi [1 ]
Imanaka, Mari [1 ]
Takeno, Ryoko [1 ]
Iguchi, Genzo [1 ]
Takahashi, Kentaro [1 ]
Okimura, Yasuhiko [2 ]
Kaji, Hidesuke [3 ]
Chihara, Kazuo [1 ]
机构
[1] Kobe Univ, Grad Sch Med, Dept Clin Mol Med, Div Endocrinol Metab Nutr & Hematol Oncol,Chuo Ku, Kobe, Hyogo 6500017, Japan
[2] Kobe Univ, Sch Med, Dept Basic Allied Med, Kobe, Hyogo, Japan
[3] Univ Hyogo, Div Physiol Metabol, Kobe, Hyogo, Japan
关键词
acromegaly; growth hormone; insulin-like growth factor-I; glucose tolerance; diabetes mellitus;
D O I
10.1159/000112590
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Acromegaly is frequently accompanied with impaired glucose tolerance (IGT) and diabetes mellitus ( DM). It remains unclear which factors determine the abnormal glucose tolerance status in acromegaly. In addition, diverse actions of GH and IGF-I in regulating glucose metabolism in acromegaly have not yet been well elucidated. The aim of this study was to investigate the factors associated with abnormal glucose tolerance in acromegaly. Subjects and Study Design: We conducted a retrospective cross-sectional study that included 48 patients with active acromegaly. The subjects were divided into two groups by the results of 75 g OGTT: normal glucose tolerance (NGT) group (n = 19) and IGT+ DM group (n = 29). Results: Systolic blood pressure (SBP) was significantly higher in the IGT+ DM than in the NGT group. Homeostasis model assessment of beta-cell function (HOMA-beta) was significantly decreased in the IGT+ DM group compared with the NGT group. Although serum GH or IGF-I levels were not different between the two groups, the IGF-I/GH ratio in the IGT+ DM group was significantly lower than that in the NGT group. Conclusions: We have shown that a low serum IGF-I/GH ratio was associated with abnormal glucose tolerance in acromegaly. We propose that the IGF-I/GH ratio is a useful marker to understand the metabolic status in acromegaly. Copyright (c) 2008 S. Karger AG, Basel.
引用
收藏
页码:165 / 171
页数:7
相关论文
共 50 条
  • [1] Biochemical markers of acromegaly: GH vs. IGF-I
    Barkan, AL
    GROWTH HORMONE & IGF RESEARCH, 2004, 14 : S97 - S100
  • [2] Effects of tamoxifen on GH and IGF-I levels in acromegaly
    Renato Cozzi
    R. Attanasio
    G. Oppizzi
    P. Orlandi
    A. Giustina
    S. Lodrini
    N. Da Re
    D. Dallabonzana
    Journal of Endocrinological Investigation, 1997, 20 : 445 - 451
  • [3] Effects of tamoxifen an GH and IGF-I levels in acromegaly
    Cozzi, R
    Attanasio, R
    Oppizzi, G
    Orlandi, P
    Giustina, A
    Lodrini, S
    DaRe, N
    Dallabonzana, D
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1997, 20 (08) : 445 - 451
  • [4] Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly
    Tanaka, Satoshi
    Fukuda, Izumi
    Hizuka, Naomi
    Takano, Kazue
    ENDOCRINE JOURNAL, 2010, 57 (06) : 477 - 483
  • [5] The biochemical diagnosis of acromegaly: revising the role of measurement of IGF-I and GH after glucose load in 5 questions
    Paragliola, Rosa Maria
    Carrozza, Cinzia
    Corsello, Salvatore M.
    Salvatori, Roberto
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2022, 17 (03) : 205 - 224
  • [6] Serum IGF-I levels in the diagnosis and monitoring of acromegaly
    Brooke, A. M.
    Drake, W. M.
    PITUITARY, 2007, 10 (02) : 173 - 179
  • [7] Serum IGF-I levels in the diagnosis and monitoring of acromegaly
    A. M. Brooke
    W. M. Drake
    Pituitary, 2007, 10 : 173 - 179
  • [8] GH, IGF-I, and growth
    Isaksson, O
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2004, 17 : 1321 - 1326
  • [9] REGULATION OF MATERNAL IGF-I BY PLACENTAL GH IN NORMAL AND ABNORMAL HUMAN PREGNANCIES
    CAUFRIEZ, A
    FRANKENNE, F
    HENNEN, G
    COPINSCHI, G
    AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (04): : E572 - E577
  • [10] GH/IGF-I normalization and tumor shrinkage during longterm treatment of acromegaly by lanreotide
    R. Attanasio
    M. Barausse
    Renato Cozzi
    Journal of Endocrinological Investigation, 2001, 24 : 209 - 216